Masetti Riccardo, D'Amico Federica, Zama Daniele, Leardini Davide, Muratore Edoardo, Ussowicz Marek, Fraczkiewicz Jowita, Cesaro Simone, Caddeo Giulia, Pezzella Vincenza, Belotti Tamara, Gottardi Francesca, Tartari Piero, Brigidi Patrizia, Turroni Silvia, Prete Arcangelo
Pediatric Oncology and Hematology "Lalla Seràgnoli", IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40138 Bologna, Italy.
Cancers (Basel). 2022 Apr 12;14(8):1932. doi: 10.3390/cancers14081932.
Febrile neutropenia (FN) is a common complication in pediatric patients receiving allogeneic hematopoietic stem cell transplantation (HSCT). Frequently, a precise cause cannot be identified, and many factors can contribute to its genesis. Gut microbiota (GM) has been recently linked to many transplant-related complications, and may also play a role in the pathogenesis of FN. Here, we conducted a longitudinal study in pediatric patients receiving HSCT from three centers in Europe profiling their GM during the transplant course, particularly at FN onset. We found that a more stable GM configuration over time is associated with a shorter duration of fever. Moreover, patients with longer lasting fever exhibited higher pre-HSCT levels of , , and and increased proportions of and at the engraftment. These results suggest a possible association of the GM with the genesis and course of FN. Data seem consistent with previous reports on the relationship of a so-called "healthy" GM and the reduction of transplant complications. To our knowledge, this is the first report in the pediatric HSCT setting. Future studies are warranted to define the underling biological mechanisms and possible clinical implications.
发热性中性粒细胞减少症(FN)是接受异基因造血干细胞移植(HSCT)的儿科患者常见的并发症。通常,无法确定确切病因,许多因素可导致其发生。肠道微生物群(GM)最近与许多移植相关并发症有关,也可能在FN的发病机制中起作用。在此,我们对来自欧洲三个中心接受HSCT的儿科患者进行了一项纵向研究,在移植过程中,特别是在FN发作时,对他们的GM进行了分析。我们发现,随着时间推移,更稳定的GM配置与发热持续时间较短有关。此外,发热持续时间较长的患者在HSCT前的 、 、 和 水平较高,且在植入时 和 的比例增加。这些结果表明GM与FN的发生和病程可能存在关联。数据似乎与先前关于所谓“健康”GM与移植并发症减少之间关系的报道一致。据我们所知,这是儿科HSCT环境中的首份报告。未来有必要开展研究以确定潜在的生物学机制和可能的临床意义。